Skeletal Dysplasia Account Manager (Southwest Region)

The Skeletal Dysplasia Account Manager is a high-impact, community-focused role central to BridgeBio’s commercial success. This individual will drive the launch of Infigratinib—a first-in-class therapy for achondroplasia—bring deep clinical acumen, urgency, and a passion for partnering with providers and families.

• →Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals.
• →Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions.

• →Use sales and target data to identify growth opportunities and address territory challenges proactively.
• →Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges.

• →Partners compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction.
• →Build and maintain relationships with KOLs in partnership with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio.
• →Operate with an “One Bridge” mindset—collaborating across the organization to execute company initiatives and represent BridgeBio with integrity.
• →Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory.
• →Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.

Southwest Region ~ Multiple territories covering the following areas:

Dallas, Houston, San Antonio, New Orleans, Nashville, Phoenix, Oklahoma City

• Business Acumen & Results Orientation: Balances priorities and leverages available resources to drive results; applies strong analytical skills to surface opportunities in the skeletal dysplasia market.
• Resilience & Confidence: Hunter’s mentality with the resilience to identify and support families living with achondroplasia across geographically dispersed centers of care.

• Build Trusting Relationships: Trusted advisor who anticipates and addresses the needs of skeletal dysplasia providers, genetic counselors, and families.
• Clinical Acumen & Learning Agility: Continuously deepens clinical knowledge of achondroplasia; sought out as a condition and product expert by HCPs and their teams.

• Influence with Impact: Engages multidisciplinary care teams—from geneticists to orthopedic specialists to community advocacy groups—with credible, complex influence strategies.

• Teamwork and Coordination: Prioritizes the community and business while collaborating closely with the Regional Sales Director and cross-functional partners to execute a successful launch.

• 8–10 years in pharmaceutical or biotech; 4+ years in rare disease, genetic disease, or skeletal dysplasia required. Achondroplasia or pediatric rare disease experience highly preferred.
• BS/BA required, MBA a plus.
• Willingness to travel extensively.
• Product/indication launch experience: Proven record of accomplishment launching products into competitive or new markets, including creating demand through disease-state and stakeholder education.
• Account management: Success analyzing complex accounts, building strategy, and driving implementation to deliver measurable impact.
• Leadership & communication: Effective communication skills and influence, both internally and externally—with high accountability, sound judgment, and excellent organizational skills.
• AI fluency: Demonstrated curiosity and adaptability with AI-powered tools and technologies.
• Integrity: Commitment to BridgeBio’s ethical standards and compliance culture.